SHP648
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SHP648, covering 2022-05-19 to 2022-05-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study of SHP648, an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia B Subjects [Phase 1, Phase 2]